Breaking News
The U.S. Food and Drug Administration has approved Libtayo (cemiplimab-rwlc) for the adjuvant, or postsurgical, treatment of adults with cutaneous squamous cell carcinoma at high risk of recurrence after surgery and radiation.
A small study of medical records unexpectedly found that 12 percent of chronic pain patients who were treated with spinal cord stimulation or an implanted pain medicine pump had a white blood cell condition called eosinophilia.
Mary E. Brunkow, PhD, Fred Ramsdell, PhD, and Shimon Sakaguchi, MD, PhD, have been awarded the Nobel Prize in Physiology or Medicine 2025 for their groundbreaking discoveries concerning peripheral immune tolerance that prevents the immune system from harming the body.
BioTrending
- By Keith Berman, MPH, MBA
Therapeutic plasma exchange may improve outcomes for patients diagnosed with sepsis or septic shock, but funding is needed to conduct needed clinical trials.
- By Trudie Mitschang
As chronic disease and aging populations drive healthcare costs higher, value-based care offers a sustainable path forward — rewarding providers for better outcomes, improved patient experiences and greater cost-efficiency.
- By Diane L.M. Cook
With a pending shortage of cardiologists, there is a growing need for remote cardiac monitoring, and now, three FDA-cleared products are transforming how this care is provided.
- By Lee Warren
The use of AI is growing at a brisk rate as healthcare professionals realize its potential as an indispensable partner in treating patients.
Awards
BSTQ is an Industry Award-Winning Journal
Since its debut in 2009, BioSupply Trends Quarterly’s articles have been recognized by some of the industry’s most prominent organizations, earning platinum and gold awards.
